Silencing of the von Willebrand factor gene in proatherothrombotic APOE∗3-Leiden.CETP transgenic mice
Background: Elevated von Willebrand factor (VWF) levels correlate with higher risk of atherosclerosis-related arterial thrombosis (atherothrombosis). Silencing the VWF gene via small-interfering RNAs (siRNAs) could mitigate this risk. Previous studies successfully delivered siRNA to the endothelium...
Saved in:
| Main Authors: | Yvonne K. Jongejan, Richard J. Dirven, Elisa Schrader Echeverri, Anke J.L. de Jong, Amanda C.M. Pronk, Sander Kooijman, Patrick C.N. Rensen, James E. Dahlman, Jeroen C.J. Eikenboom, Bart J.M. van Vlijmen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Research and Practice in Thrombosis and Haemostasis |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2475037925000238 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Probing rare von Willebrand disease–causing mutations in the D4 and C-domains of von Willebrand factor
by: Golzar Mobayen, et al.
Published: (2025-05-01) -
von Willebrand Factor (VWF) Inhibitors in Two Brothers with von Willebrand Disease: A Case Report
by: Claudia Djambas Khayat, et al.
Published: (2025-01-01) -
Sexuality and bleeding in von Willebrand disease
by: Calvin B. van Kwawegen, et al.
Published: (2025-02-01) -
Intraindividual variability of von Willebrand factor and the need for repeated testing
by: Malene Helligsø Kirkeby, et al.
Published: (2025-05-01) -
Prognostic value of von Willebrand factor in clinical practice
by: K. N. Grigoreva, et al.
Published: (2022-11-01)